1. Home
  2. TXMD vs VRME Comparison

TXMD vs VRME Comparison

Compare TXMD & VRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TXMD
  • VRME
  • Stock Information
  • Founded
  • TXMD 2008
  • VRME 1999
  • Country
  • TXMD United States
  • VRME United States
  • Employees
  • TXMD N/A
  • VRME N/A
  • Industry
  • TXMD Biotechnology: Pharmaceutical Preparations
  • VRME EDP Services
  • Sector
  • TXMD Health Care
  • VRME Technology
  • Exchange
  • TXMD Nasdaq
  • VRME Nasdaq
  • Market Cap
  • TXMD 12.7M
  • VRME 11.0M
  • IPO Year
  • TXMD N/A
  • VRME N/A
  • Fundamental
  • Price
  • TXMD $1.06
  • VRME $0.81
  • Analyst Decision
  • TXMD
  • VRME Strong Buy
  • Analyst Count
  • TXMD 0
  • VRME 2
  • Target Price
  • TXMD N/A
  • VRME $1.50
  • AVG Volume (30 Days)
  • TXMD 17.5K
  • VRME 145.2K
  • Earning Date
  • TXMD 11-11-2025
  • VRME 11-11-2025
  • Dividend Yield
  • TXMD N/A
  • VRME N/A
  • EPS Growth
  • TXMD N/A
  • VRME N/A
  • EPS
  • TXMD N/A
  • VRME N/A
  • Revenue
  • TXMD $2,559,000.00
  • VRME $22,071,000.00
  • Revenue This Year
  • TXMD $427.09
  • VRME N/A
  • Revenue Next Year
  • TXMD N/A
  • VRME $5.98
  • P/E Ratio
  • TXMD N/A
  • VRME N/A
  • Revenue Growth
  • TXMD 156.93
  • VRME N/A
  • 52 Week Low
  • TXMD $0.70
  • VRME $0.55
  • 52 Week High
  • TXMD $2.44
  • VRME $5.00
  • Technical
  • Relative Strength Index (RSI)
  • TXMD 40.43
  • VRME 43.09
  • Support Level
  • TXMD $1.06
  • VRME $0.80
  • Resistance Level
  • TXMD $1.14
  • VRME $0.85
  • Average True Range (ATR)
  • TXMD 0.05
  • VRME 0.05
  • MACD
  • TXMD -0.00
  • VRME -0.01
  • Stochastic Oscillator
  • TXMD 5.26
  • VRME 7.42

About TXMD TherapeuticsMD Inc.

TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.

About VRME VerifyMe Inc.

VerifyMe Inc together with its subsidiaries, is a traceability and customer support services provider using specialized software and process technology. The company operates a Precision Logistics Segment and an Authentication Segment to provide specialized logistics for time-and-temperature sensitive products, as well as item-level traceability, anti-diversion and anti-counterfeit protection, brand protection and enhancement technology solutions. It Generates the majority of its revenue from the Precision Logistics Segment. Through its Precision Logistics segment, it provides a value-added service for sensitive parcel management driven by a proprietary software platform that provides predictive analytics from key metrics such as pre-shipment weather analysis, flight-tracking, and Others.

Share on Social Networks: